Hereditary hemorrhagic telangiectasia

Request an Appointment
Print

Departments and specialties

Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens of specialties work together to ensure quality care and successful recovery.

Departments that treat this condition

Areas that research this condition

Research

Mayo Clinic researchers are studying how HHT affects the brain, lungs, digestive tract and liver. They're also assessing the role of oral medications such as pazopanib (Votrient) and pomalidomide (Pomalyst) for the management of severe HHT-related bleeding.

Publications

See a list of publications about hereditary hemorrhagic telangiectasia by Mayo Clinic doctors on PubMed, a service of the National Library of Medicine.

By Mayo Clinic Staff

Hereditary hemorrhagic telangiectasia care at Mayo Clinic

Request an appointment
Diagnosis & treatmentCare at Mayo Clinic
Dec. 28, 2022
Print

Living with hereditary hemorrhagic telangiectasia?

Connect with others like you for support and answers to your questions in the Blood Cancers & Disorders support group on Mayo Clinic Connect, a patient community.

Blood Cancers & Disorders Discussions

See more discussions

Related

Products & Services

Hereditary hemorrhagic telangiectasia

Research: It's all about patients

[MUSIC PLAYING]

Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is to advance how we can best help the patient, how to make sure the patient comes first in care. So in many ways, it's a cycle. It can start with as simple as an idea worked on in a laboratory, brought to the patient bedside, and if everything goes right — and let's say it's helpful or beneficial — then brought on as a standard approach. And I think that is one of the unique characteristics of Mayo's approach to research — that patient-centeredness — that really helps to put it in its own spotlight.